2000
DOI: 10.1002/1520-7560(200009/10)16:1+<::aid-dmrr134>3.0.co;2-n
|View full text |Cite
|
Sign up to set email alerts
|

Management of the diabetic Charcot foot

Abstract: The diabetic Charcot foot is a major limb-threatening complication of long-term diabetes mellitus and neuropathy. Although first described over 100 years ago, we are still lacking definitive studies regarding its prevalence in this population, precise etiology, or most effective treatments. Trauma in the presence of peripheral sensory neuropathy and abundant arterial perfusion seem to be the primary causal factors leading to this severe foot deformity. Misdiagnosis or delayed diagnosis of osteoarthropathy allo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
20
0
8

Year Published

2005
2005
2022
2022

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 58 publications
(29 citation statements)
references
References 37 publications
0
20
0
8
Order By: Relevance
“…[17][18][19] The coefficient of variation (CV) from 8 measurements over a 4-week period on a cadaver foot phantom was 2.2% for estimated BMD. 17 The intraclass correlation coefficient (ICC [3,1]) calculated from test-retest measurements at a 1-week interval on 20 subjects without known pathology or impairments was .97 for estimated BMD. 17 The manufacturer of the Sahara Clinical Bone Sonometer reported the average test-retest measurement difference for estimated BMD to be 0.014 g/cm 2 .…”
Section: Tests and Measuresmentioning
confidence: 99%
See 2 more Smart Citations
“…[17][18][19] The coefficient of variation (CV) from 8 measurements over a 4-week period on a cadaver foot phantom was 2.2% for estimated BMD. 17 The intraclass correlation coefficient (ICC [3,1]) calculated from test-retest measurements at a 1-week interval on 20 subjects without known pathology or impairments was .97 for estimated BMD. 17 The manufacturer of the Sahara Clinical Bone Sonometer reported the average test-retest measurement difference for estimated BMD to be 0.014 g/cm 2 .…”
Section: Tests and Measuresmentioning
confidence: 99%
“…2 Although the cause of neuropathic arthropathy of the foot remains poorly understood, it may be affected by low bone mineral density (BMD) of the foot or ankle and by the presence and severity of peripheral neuropathy (autonomic and somatic). [2][3][4] An injury to the foot may initiate an unregulated and prolonged inflammatory response in patients with DM and peripheral neuropathy. A warm, swollen, and reddened foot marks the acute neuropathic arthropathy process.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Распространенность данного осложнения среди больных сахарным диабетом составляет менее 1 % [2], хотя в литературе можно обнаружить информацию о различных проявлениях ДНОАП у 18-25 % лиц с длительностью диабета более 20 лет [3,4]. Такая про-тиворечивость сведений, очевидно, связана с разли-чиями в методике обследования и разными критери-ями диагностики нейроостеоартропатии.…”
Section: Introductionunclassified
“…It is estimated that up to 15% of all foot ulcers will result in amputations (Frykberg et al, 2000). Diabetic foot ulcers are usually the consequences of diabetes associated peripheral neuropathy and vascular disease affecting both the macro-and microvasculature.…”
Section: The Role Of Tumor Necrosis Factor α In Wound Healingmentioning
confidence: 99%